Variables used to describe variation in sediment transport. by Andrew Kulmatiski (833256)

Subjects:

Model summary and variance in sediment transport explained by each model. by Andrew Kulmatiski (833256)

Subjects:

Mean sediment transport (g m^-2 day^-1) by grazing condition (Grazed, Some Graze, and No Graze). by Andrew Kulmatiski (833256)

Subjects:

Data_Sheet_1_Subthreshold amyloid deposition, cerebral small vessel disease, and functional brain network disruption in delayed cognitive decline after stroke.docx by Jae-Sung Lim (532986)

“…We postulated that the functional segregation observed during post-stroke compensation could be disrupted by underlying amyloid pathology or cerebral small vessel disease (cSVD), leading to delayed-onset PSCD.…”

Data Sheet 1_Host and bacterial urine proteomics might predict treatment outcomes for immunotherapy in advanced non-small cell lung cancer patients.docx by David Dora (10278141)

“…In this study, we aimed to evaluate the predictive role of the host and bacterial urine extracellular vesicle (EV) proteomes in patients with non-small cell lung cancer (NSCLC) treated with anti-PD1 immunotherapy.…”

Data Sheet 1_“Heads Up Girls!” a training intervention to improve scanning behavior in youth female football.pdf by Mirjam Hintermann (11172186)

“…Scanning behavior was assessed using video analysis of 4v4 small-sided games in pre-, post-, and retention tests. …”

Data Sheet 2_“Heads Up Girls!” a training intervention to improve scanning behavior in youth female football.pdf by Mirjam Hintermann (11172186)

“…Scanning behavior was assessed using video analysis of 4v4 small-sided games in pre-, post-, and retention tests. …”

Figure 2 from Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in <i>EGFR</i>- and <i>KRAS</i>-Mutant Lung Cancer by Xiaoxiao Sun (20589448)

<i>KDM4B/DHX9</i> promotes chemoresistance in small cell lung cancer through <i>MYCN</i>-Driven signaling pathway by Qiong Lyu (22448644)

“…<p dir="ltr">Small cell lung cancer (SCLC) is prone to developing chemoresistance, which is associated with epigenetic reprogramming. …”

Study of Resonance in Wind Parks by Qing Mu (19655194)

Table 1_Head circumference percentiles in Indian children with Down syndrome.docx by Harvinder Kaur (21188768)

“…Our study showed that 12.9% of Down syndrome cases had normal head circumference, 27.2% had small heads, and the majority, 59.9%, had microcephaly. …”

Data Sheet 1_Social-ecological vulnerability of small-scale farming in the southern Andes: the role of Indigenous and Local Ecological Knowledge in adaptation to climate variabilit... by Paulina Rodríguez-Díaz (21597755)

“…<p>Small-scale farming is highly vulnerable to climate variability due to the increased uncertainty in production processes caused by short-term changes in precipitation and temperatures. …”

Table 2_Risk of interstitial lung disease in non-small cell lung cancer treated with EGFR-TKI: a real-world pharmacovigilance study.docx by Xu Miao (22142455)

“…Background<p>Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have emerged as a mainstay for patients diagnosed with non-small cell lung cancer (NSCLC). However, interstitial lung disease (ILD), potentially fatal, may develop in certain patients during EGFR-TKI therapy. …”

Table 1_Risk of interstitial lung disease in non-small cell lung cancer treated with EGFR-TKI: a real-world pharmacovigilance study.docx by Xu Miao (22142455)

“…Background<p>Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have emerged as a mainstay for patients diagnosed with non-small cell lung cancer (NSCLC). However, interstitial lung disease (ILD), potentially fatal, may develop in certain patients during EGFR-TKI therapy. …”

Table 3_Risk of interstitial lung disease in non-small cell lung cancer treated with EGFR-TKI: a real-world pharmacovigilance study.docx by Xu Miao (22142455)

“…Background<p>Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have emerged as a mainstay for patients diagnosed with non-small cell lung cancer (NSCLC). However, interstitial lung disease (ILD), potentially fatal, may develop in certain patients during EGFR-TKI therapy. …”

Average activation of the prefrontal cortex during cognitive dual task obtained from fNIRS data of all trials and participants. by Jungsoo Lee (243853)

Supplementary file 1_International cost-effectiveness analysis in osimertinib after chemoradiotherapy in stage III EGFR-mutated non-small cell lung cancer.docx by Diya Tang (12021791)

Table 3_High-dose ascorbic acid synergizes with anti-PD1 therapy in non-small cell lung cancer in vitro and in vivo models.xlsx by Hak Su Kim (11707346)

“…Introduction<p>Immune checkpoint inhibitors(ICIs) targeting programmed cell death protein 1 (PD1) confer significant survival benefits to patients with non-small cell lung cancer (NSCLC). However, there remains a substantial unmet need to identify therapeutic approaches to overcome resistance and provide benefits to these patients. …”

Table 2_High-dose ascorbic acid synergizes with anti-PD1 therapy in non-small cell lung cancer in vitro and in vivo models.xlsx by Hak Su Kim (11707346)

“…Introduction<p>Immune checkpoint inhibitors(ICIs) targeting programmed cell death protein 1 (PD1) confer significant survival benefits to patients with non-small cell lung cancer (NSCLC). However, there remains a substantial unmet need to identify therapeutic approaches to overcome resistance and provide benefits to these patients. …”

Image 1_Small-molecule MMRi36 induces apoptosis in p53-mutant lymphomas by targeting MDM2/MDM4/XIAP for degradation.jpg by Rati Lama (846107)

“…Therefore, MMRi36 is a novel prototype small-molecule for targeting MDM2/MDM4/XIAP for degradation and induction of apoptosis in p53-mutant lymphomas.…”